US Patent Issued to WNL BIOMED TECH, Zhong'ao Biomedical Technology (Guangdong) on Aug. 11 for "Application of Caerin 1.1/1.9 combined with anti-CD47 antibody in preparing drug for treating melanoma" (Australian, Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,702, issued on Aug. 11, was assigned to WNL BIOMED TECH Pty LTD. (Brisbane, Australia) and Zhong'ao Biomedical Technology (Guangdong) Co. Ltd (Zhongshan, China).

"Application of Caerin 1.1/1.9 combined with anti-CD47 antibody in preparing drug for treating melanoma" was invented by Xiaosong Liu (Brisbane, Australia), Junjie Li (Zhongshan, China), Guoying Ni (Brisbane, Australia) and Tianfang Wang (Brisbane, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the field of biotechnology, and particularly relates to an application of Caerin 1.1/1.9 combined with an anti-CD47 antibody in preparing a drug for treatin...